TD Asset Management
IMVT icon

TD Asset Management’s Immunovant IMVT Stock Holding History

TD Asset Management’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.95M Sell
76,540
-54,812
-42% -$1.67M ﹤0.01% 905
2026
Q1 		$3.26M Sell
131,352
-93,608
-42% -$2.42M ﹤0.01% 871
2025
Q4 		$5.72M Buy
224,960
+89,206
+66% +$1.99M ﹤0.01% 776
2025
Q3 		$2.19M Sell
135,754
-56,752
-29% -$919K ﹤0.01% 944
2025
Q2 		$3.08M Buy
192,506
+10,108
+6% +$153K ﹤0.01% 844
2025
Q1 		$3.12M Buy
182,398
+30,152
+20% +$631K ﹤0.01% 862
2024
Q4 		$3.77M Buy
152,246
+67,246
+79% +$1.91M ﹤0.01% 845
2024
Q3 		$2.38M Buy
85,000
+48,200
+131% +$1.42M ﹤0.01% 978
2024
Q2 		$972K Sell
36,800
-32,242
-47% -$917K ﹤0.01% 1167
2024
Q1 		$2.23M Buy
69,042
+2,734
+4% +$99.7K ﹤0.01% 981
2023
Q4 		$2.79M Buy
66,308
+35,108
+113% +$1.29M ﹤0.01% 903
2023
Q3 		$1.2M Buy
+31,200
New +$705K ﹤0.01% 1103
2023
Q2 		– Sell
-29,900
Closed -$464K – 1441
2023
Q1 		$464K Buy
29,900
+11,100
+59% +$193K ﹤0.01% 1276
2022
Q4 		$334K Buy
+18,800
New +$237K ﹤0.01% 1342
2021
Q1 		– Sell
-16,300
Closed -$753K – 1516
2020
Q4 		$753K Buy
16,300
+5,117
+46% +$237K ﹤0.01% 1247
2020
Q3 		$394K Buy
+11,183
New +$336K ﹤0.01% 1291

Other funds holding IMVT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

TD Asset Management's IMVT Position: Q2 2026 in Review

TD Asset Management reduced its Immunovant (IMVT) stake by 42% in Q2 2026, selling an estimated $1.67M and leaving 76,540 shares worth $2.95M. The position accounts for ﹤0.01% of the portfolio, ranked #905.

TD Asset Management first reported a position in IMVT in Q3 2020 and has held it in 16 quarters since. The position peaked at $5.72M in Q4 2025. 152 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • TD Asset Management held 76,540 shares of Immunovant worth $2.95M as of Q2 2026.
  • TD Asset Management sold 54,812 Immunovant shares in Q2 2026, an estimated $1.67M.
  • Immunovant made up ﹤0.01% of TD Asset Management's portfolio in Q2 2026, its #905 holding.
  • TD Asset Management first reported a position in Immunovant in Q3 2020 and has held it in 16 quarters since.
  • TD Asset Management's Immunovant position peaked at $5.72M in Q4 2025.
  • 152 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on TD Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.